Skip to main content

Clifford Chance

Clifford Chance
Leigh Oliver (She/Her)

Leigh Oliver (She/Her)

Partner, Co-Head of the Healthcare and Life Sciences Sector and Head of US Antitrust Practice

Partner, Co-Head of the Healthcare and Life Sciences Sector and Head of US Antitrust Practice
Leigh Oliver (She/Her)

Leigh Oliver is Head of the US Antitrust Practice, Co-Head of the Healthcare & Life Sciences Sector and specializes in antitrust issues ranging from bet-the-company merger control matters to state and federal antitrust investigations. She has two decades of experience advising clients in heavily scrutinized industries, including healthcare, life sciences, aerospace and defense and industrials. She regularly represents clients before federal and state antitrust agencies and in merger litigation in federal court.

  • Mondelēz International in the sale of its gum business to Perfetti Van Melle
  • UnitedHealth Group and its subsidiary Optum on various matters, including the successful defense of its acquisition of Change Healthcare which was challenged by U.S. Department of Justice Antitrust Division
  • Laboratory Corporation of America with respect to numerous transactions
  • Alcon in various transactions
  • Einstein Health Network in its 2020 merger with Thomas Jefferson University
  • Beaumont Health in its merger with Spectrum Health
  • Aspirus Inc. in its acquisition of Ascension hospitals in Wisconsin
  • Penn State Health in its acquisition of Geinsinger’s Holy Spirit Hospital
  • Atrium and Wake Forest Baptist Medical Center in their combination
  • UW Health and UnityPoint in their combination of provider and plan businesses
  • PPG, Inc. in various transactions and matters
  • Gencorp-Aerojet in its acquisition of Pratt & Whitney Rocketdyne
  • Orbital Sciences in its acquisition of ATK

News and client work

View all news and client work featuring Leigh Oliver

Contact details

Career and qualifications

  • Haverford College (BA Political Science) 2000
  • The Catholic University of America, Columbus School of Law (JD) 2004
  • Admitted as Attorney-at-Law in the District of Columbia 2004
  • Joined Clifford Chance as a Partner 2022

Professional bodies

  • Member of the Council of the ABA Antitrust Section
  • Member of the American Health Law Association (AHLA). She has been She was also listed in the 2025 edition of Lawdragon 500 - Leading Litigators in America.
  • 2025 Lawdragon 500 Leading Litigators in America

Awards and citations

  • Ranked among the top lawyers for Antitrust by Chambers USA for four consecutive years from 2021 – 2024
  • Recommended for Competition: Global Leaders in Who's Who Legal, 2024